The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study.

Yıldırım H. Ç., Kutlu Y., Mutlu E., Aykan M. B., Korkmaz M., Yalçın S., ...More

International journal of clinical oncology, vol.29, pp.258-265, 2024 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 29
  • Publication Date: 2024
  • Doi Number: 10.1007/s10147-023-02460-5
  • Journal Name: International journal of clinical oncology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, MEDLINE
  • Page Numbers: pp.258-265
  • Keywords: Male breast cancer, CDK4/6 inhibitors, Palbociclib, Ribociclib
  • Dokuz Eylül University Affiliated: Yes